Clinical use of nefazodone in major depression: a 6-year perspective.
Schatzberg
Alan F
AF
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Calif 94305-5717, USA. afschatz@Stanford.edu
Prather
Maureen R
MR
Keller
Martin B
MB
Rush
A John
AJ
Laird
Lyle K
LK
Wright
Clinton W
CW
D000367:Age Factors; D018687:Antidepressive Agents, Second-Generation / Q000494:pharmacology / Q000627:therapeutic use*; D002908:Chronic Disease; D003866:Depressive Disorder / Q000188:drug therapy*; D006760:Hospitalization; D006801:Humans; D015201:Meta-Analysis as Topic; D010879:Piperazines; D016032:Randomized Controlled Trials as Topic; D055502:Secondary Prevention; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D012890:Sleep / Q000187:drug effects; D014230:Triazoles / Q000494:pharmacology / Q000627:therapeutic use*
D018687:Antidepressive Agents, Second-Generation; D010879:Piperazines; D017367:Selective Serotonin Reuptake Inhibitors; D014230:Triazoles; C051752:nefazodone